Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services

Psychiatric Services

Volumn 47, Issue 3, 1996, Pages 282-286

  Segal, Steven P ^a   Bola, John R ^a   Watson, Margaret A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b W Montana Reg Mental Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CULTURAL FACTOR; DOCTOR PATIENT RELATION; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL DISEASE; MENTAL HEALTH SERVICE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PATIENT CARE; PRESCRIPTION; RACE DIFFERENCE;

EID: 0029864174     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.47.3.282     Document Type: Article

References (39)

1. Pilowsky LS, Ring H, Shine PJ, et al. Rapid tranquilisation: a survey of emergency prescribing in a general psychiatric hospital British Journal of Psychiatry 160:831-835, 1992
2. Jacobs D: Psychopharmacologic management of the psychiatric emergency patient. General Hospital Psychiatry 6.203-210, 1984
3. Snowden LR, Holschuh J. Ethnic differences in emergency psychiatric care and hospitalization in a program for the severely mentally ill. Community Mental Health Journal 28 281-291, 1992
4. Hu T, Snowden LR, Jerrell JM, et al: Ethnic populations in public mental health. services choice and level of use. American Journal of Public Health 81:1429-1434, 1991
5. Bond WS: Ethnicity and psychotropic drugs. Clinical Pharmacology 10.467-470. 1991
6. Lin KM, Poland RE, Lesser IM: Ethnicity and psychopharmacology. Culture, Medicine, and Psychiatry 10.151-165, 1986
7. Jann MW, Lam YWF, Chang WH: Haldoperidol and reduced haldoperidol plasma concentrations in different ethnic populations and interindividual variabilities in haldoperidol metabolism, in Psychopharmacology and Psychobiology of Ethnicity. Edited by Lin KM, Poland RE, Nakasaki G. Washington, DC, American Psychiatric Press, 1993
8. Hillard JR Biological treatment principles, in Manual of Clinical Emergency Psychiatry Edited by Hillard JR Washington, DC. American Psychiatric Press, 1990
9. Drug Evaluations Annual. Milwaukee, Wise, American Medical Association, 1991
10. Kaplan HI, Sadock BJ: Synopsis of Psychiatry, 6th ed. Baltimore, Williams & Wilkins, 1991
11. Rund DA, Hutzler JC: Emergency Psychiatry. St Louis, Mosby, 1983
12. Slaby AE: Emergency psychiatry, an update, in Emergency Psychiatry. Edited by Mezzich JE, Zimmer B Madison, Conn, International Universities Press, 1990
13. Dubin WR, Weiss KJ, Dorn JM: Pharmacotherapy of psychiatric emergencies. Journal of Clinical Psychopharmacology 6.210-222, 1986
14. Extein I. Psychopharmacology in psychiatric emergencies, in Emergency Psychiatry. Edited by Mezzich JE, Zimmer B. Madison, Conn, International Universities Press, 1990
15. Donlon PT, Hopkin J, Tupin JP: Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol American Journal of Psychiatry 136:273-278, 1979
16. Slaby AE: Other psychiatric emergencies, in Comprehensive Textbook of Psychiatry, 5th ed. Edited by Kaplan HI, Sadock BJ. Baltimore, Williams & Wilkins, 1989
17. Gelenberg AJ: Psychoses, in The Practitioner's Guide to Psychoactive Drugs, 2nd ed. Edited by Bassuk EL, Gelenberg AJ. New York, Plenum, 1983
18. Bassuk EL, Skodol AE: The first few minutes: identifying and managing life-threatening emergencies, in Psychiatric Emergency: Concepts, Methods, and Practices. Edited by Bassuk E, Birk L, Birk AW. New-York, Plenum, 1984
19. Ellison JM, Hughes DH, White KA: An emergency psychiatry update. Hospital and Community Psychiatry 40:250-260, 1989
20. Neborsky R, Janowsky D, Munson E, et al. Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Archives of General Psychiatry 38:195-199, 1981
21. Escobar JI, Barron A, Kiriakos R: A controlled study of neuroleptization with fluphenazine hydrochloride injections. Journal of Clinical Psychopharmacology 3. 359-362, 1983
22. Baldessarini RJ, Cohen BM, Teicher MN. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry 45 79-91, 1988
23. Solano OA, Sadow T, Ananth J: Rapid tranquilization: a reevaluation. Neuropsychobiology 22:90-96, 1989
24. Segal SP, Egley L, Watson MA, et al. Factors in the quality of patient evaluations in general hospital psychiatric emergency services. Psychiatric Services 46:1144-1148, 1995
25. Corrigan PW, Liberman RP, Engel JD: From noncompliance to collaboration in the treatment of schizophrenia Hospital and Community Psychiatry 41:1203-1211, 1990
26. Rosenberg RC, Kesselman M. The therapeutic alliance and the psychiatric emergency room Hospital and Community Psychiatry 44.78-80, 1993
27. Schooler NR: The role of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine. Pharmacopsychiatry 9.159-169, 1976
28. Inderbitzin LB, Lewine RJ, Gloersen BA, et al: Fluphenazine decanoate: a clinical problem? American Journal of Psychiatry 146:88-91, 1989
29. Schaffer CB, Shahid AJ, Javaid I, et al: Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients. Journal of Clinical Psychopharmacology 4: 274-277, 1982
30. Foreman A, Ohman R: Applied pharmacokinetics of haloperidol in man. Current Therapeutic Research 21.396-411, 1977
31. Segal SP, Watson MA, Nelson LS. Indexing civil commitment in psychiatric emergency rooms Annals of the American Academy of Political and Social Science 484:56-69, 1986
32. Segal SP, Watson MA, Nelson LS: Application of involuntary admission criteria in psychiatric emergency rooms. Social Work 30:160-166, 1985
33. Segal SP, Watson MA, Goldfinger SM, et al. Civil commitment in the psychiatric emergency room: I. the assessment of dangerousness by emergency room clinicians. Archives of General Psychiatry 45:748-752, 1988
34. Segal SP, Watson MA, Goldfinger SM, et al. Civil commitment in the psychiatric emergency room: II mental disorder indicators and three dangerousness criteria. Archives of General Psychiatry 45:753-758, 1988
35. Segal SP, Watson MA, Goldfinger SM, et al: Civil commitment in the psychiatric emergency room: III. disposition as a function of mental disorder and dangerousness indicators. Archives of General Psychiatry 45: 759-763, 1988
36. Endicott J, Spitzer RL, Fleiss J, et al. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33.766-771, 1976
37. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC, American Psychiatric Association, 1980
38. Segal SP, Eagley L, Watson M, et al. A Model for Assessment of Quality of Care in the psychiatric emergency service. Working paper. Berkeley, University of California, School of Social Welfare, Mental Health and Social Welfare Research Group, Winter 1993
39. Baldessarini RJ, Katz B, et al. Dissimilar dosing with high-potency and low-potency neuroleptics. American Journal of Psychiatry 141:748-752, 1984